Journals / Trends in pediatrics / 2022 / Cilt: 3 - Sayı: 2

Therapeutic Plasma Exchange for Treating Pediatric Neurological Diseases

Pages
47–50
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: When TPE is applied with appropriate indications and by an experienced team in pediatric neurological diseases, treatment results can are satisfactory, its effectiveness increases and the complication rate decreases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Therapeutic plasma exchange (TPE) is performed in various neurological, hematological, renal and autoimmune diseases.
📊
Key Findings & Data:Methods: In this study, patients who were hospitalized in the pediatric intensive care unit of a tertiary university hospital between January 2017 and December 2021 and underwent TPE due to neurological diseases were evaluated retrospectively.
💡
Conclusion & Impact:Conclusion: When TPE is applied with appropriate indications and by an experienced team in pediatric neurological diseases, treatment results can are satisfactory, its effectiveness increases and the complication rate decreases.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Therapeutic plasma exchange (TPE) is performed in various neurological, hematological, renal and autoimmune diseases. This study was conducted to determine the indications, efficacy, safety and complications of TPE in pediatric autoimmune neurological diseases. Methods: In this study, patients who were hospitalized in the pediatric intensive care unit of a tertiary university hospital between January 2017 and December 2021 and underwent TPE due to neurological diseases were evaluated retrospectively. Results: A total of 20 patients were included in the study. Their ages ranged from 6 to 237 months, with a mean age of 63.16±183.12 months. Neurological TPE indications of the patients were autoimmune encephalitis (50%, n=10), Guillain-Barre Syndrome (45%, n=9) and Acute Demyelinating Encephalomyelitis (6.7%, n=1), respectively. Catheter occlusion was observed in 2 (10%) patients, allergic reaction in 1 (5%) patient, and hypotension in 1 (5%) patient as complications of TPE. Muscle strength of patients with GBS was evaluated according to the Medical Research Council scale before transfer to the service. It was determined that the score increased from 0 to 1 in two patients, from 0 to 3 in three patients, and from 1 to 5 in four patients. In 9 of the patients diagnosed with encephalitis, regression of acute phase reactants and improvement in neurological evaluation were observed. Conclusion: When TPE is applied with appropriate indications and by an experienced team in pediatric neurological diseases, treatment results can are satisfactory, its effectiveness increases and the complication rate decreases.

🔖

Cite This Article

Erdoğan, S., Atay, G., Tuğrul, H. C., İşcan, H., Yazar, H., Kutlubay, B. (2022). Therapeutic Plasma Exchange for Treating Pediatric Neurological Diseases. Trends in pediatrics, Cilt: 3 - Sayı: 2, 47–50. https://ajindex.com/articles/598875

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019;34:171-354
  2. Hughs RA, Chevret S, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2017;2:CD001798
  3. Borras-Novell C, García Rey E, Perez Baena LF, Garcia IJ, Cahiz DC, Cambra F. Therapeutic plasma exchange in acute disseminated encephalomyelitis in children. J Clin Apher. 2015;30:335-39
  4. Stingle C, Cardinale K, Van Mater H. An Update on the Treatment of Pediatric Autoimmune Encephalitis. Curr Treat Options Rheumatol. 2018;4:14-28
  5. Hermans G, Clerckx B, Vanhullebusch T, et al. Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit. Muscle Nerve. 2012;45:18-25
  6. Korinthenberg R, Trollmann R, Felderhoff-Muser U, et al. Diagnosisi and treatment of Guillain-Barre Syndrome in childhood and adolescence: An evidence-and consensus-based guidline. Eur J Paediatr Neurol. 2020;25:5- 16
  7. Wang CX. Assessment and management of acute disseminated encephalomyelitis in the pediatric patient. Paediatr Drugs. 2021;23:213- 21
  8. Ipe TS, Meyer EK, Sanford KW, Joshi SK, Wong ECC, Raval JS. Use of therapeutic plasma exchange for pediatric neurological diseases. Clin Apher. 2021;36:161-76
  9. Naik A, Prakash S, Ray GK, Mukherjee S. Variable response to therapeutic plasma exchange in pediatric anti-NMDA receptor encephalitis. Transfus Clin Biol. 2021;28:287-90
  10. Suppiej A, Nosadini M, Zuliani L, et al. Plasma exchange in pediatric anti- NMDAR encephalitis: A systematic review. Brain Dev. 2016;38:613-22
  11. Özkale M, Erol I, Özkale Y, Kozanoğlu İ. Oveview of therapeutic plasma Exchange in pediatric neurology:a single center experience. Acta Neurol Belg. 2018;118:451-58
  12. Eyre M, Hacohen Y, Lamb K, et al. Utility and safety of plasma exchange in paediatric neuroimmune disorders. Dev Med Child Neurol. 2019;61:540- 46
  13. Suppiej IA, Nosadini M, Zuliani L, et al. Plasma exchange in pediatric anti- NMDAR encephalitis: a systematic review. Brain Dev. 2016;38:613-22
  14. Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother. 2015;15:1391-419
  15. Savransky A, Rubstein A, Rios MH, et al. Prognostic indicators of improvement with therapeutic